EyePoint (EYPT) Change in Inventory (2018 - 2026)
EyePoint (EYPT) posted Change in Inventory of -$563000.0 for Q1 2026, down 89.56% sequentially from -$297000.0 in Q4 2025, and down 219.89% YoY from $469611.4 in Q1 2025.
Powered by 
Analysis
EyePoint (EYPT) Change in Inventory (2018 - 2026) Analysis & Trends
EyePoint has reported Change in Inventory for 9 years, with the latest figure at -$563000.0 in Q1 2026.
- Quarterly Change in Inventory fell 219.89% year-over-year to -$563000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$879000.0 (up 58.67% YoY) and the FY2025 annual result came in at -$492000.0, up 69.25% from the prior year.
- Change in Inventory retreated to -$563000.0 in Q1 2026 per EYPT's latest filing, from -$297000.0 in the prior quarter.
- Over five years, Change in Inventory peaked at $1.2 million in Q1 2023 and troughed at -$865000.0 in Q3 2024.
- A 5-year average of -$20117.6 and a median of -$176000.0 in 2025 frame the typical range for Change in Inventory.
- The sharpest annual moves came in 2023 and 2024: Change in Inventory jumped 982.93% in 2023, then slumped 374.6% in 2024.
- Over 5 years, Change in Inventory stood at $845000.0 in 2022, then plunged by 179.41% to -$671000.0 in 2023, then climbed by 25.19% to -$502000.0 in 2024, then jumped by 40.84% to -$297000.0 in 2025, then plunged by 89.56% to -$563000.0 in 2026.
- According to Business Quant data, Change in Inventory over the past three periods registered -$563000.0, -$297000.0, and -$568000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 132.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 47.15 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -280,000.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 12.97 Mn |
| 10 | EyePoint | 398.53 Mn | 218.06 Mn | 507,000.00 | 632,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 632,000.00 |
| Mar 31, 2026 | -563,000.00 |
| Dec 31, 2025 | -297,000.00 |
| Sep 30, 2025 | -568,000.00 |
| Jun 30, 2025 | 549,000.00 |
| Mar 31, 2025 | -176,000.00 |
| Dec 31, 2024 | -502,000.00 |
| Sep 30, 2024 | -865,000.00 |
| Jun 30, 2024 | -584,000.00 |
| Mar 31, 2024 | 351,000.00 |
| Dec 31, 2023 | -671,000.00 |
| Sep 30, 2023 | 315,000.00 |
| Jun 30, 2023 | 724,000.00 |
| Mar 31, 2023 | 1.19 Mn |
| Dec 31, 2022 | 845,000.00 |
| Sep 30, 2022 | 277,000.00 |
| Jun 30, 2022 | -82,000.00 |
| Mar 31, 2022 | -280,000.00 |
| Dec 31, 2021 | -580,000.00 |
| Sep 30, 2021 | -810,000.00 |